exscientia

News

Exscientia CEO sacked for 'inappropriate' staffer relations

UK biotech Exscientia has terminated the employment of its founder and chief executive, Dr Andrew Hopkins, effective immediately, over what is described as “inappropriate

Digital

AI drug discovery: Where we are and where we’re going

The promise of AI in pharma is sprouting up across the business, from marketing to manufacturing to R&D.

News

Exscientia trims pipeline to focus on top cancer prospects

UK biotech Exscientia has tapped the brakes on the rapid expansion of its R&D pipeline, narrowing its in-house activities to oncology programmes that it says offer the

News

Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals

German group Merck has revved up its artificial intelligence-powered drug discovery with partnerships with two UK companies – Exscientia and BenevolentAI – that will focus

R&D